IL-1 Receptor Antagonist Reduced Chemical-Induced Keratinocyte Apoptosis through Antagonism to IL-1α/IL-1β
Authors:
Open Access
- 1 July 2018
- journal article
- research article
- Published by The Korean Society of Applied Pharmacology in Biomolecules & Therapeutics
- Vol. 26 (4) , 417-423
Abstract
Extracellular interleukin 1 alpha (IL-1 alpha) released from keratinocytes is one of the endpoints for in vitro assessments of skin irritancy. Although cells dying via primary skin irritation undergo apoptosis as well as necrosis, IL-1 alpha is not released in apoptotic cells. On the other hand, active secretion has been identified in interleukin-1 receptor antagonist (IL-1ra), which was discovered to be a common, upregulated, differentially-expressed gene in a microarray analysis performed with keratinocytes treated using cytotoxic doses of chemicals. This study examined whether and how IL-1ra, particularly extracellularly released IL-1ra, was involved in chemically-induced keratinocyte cytotoxicity and skin irritation. Primary cultured normal adult skin keratinocytes were treated with cytotoxic doses of chemicals (hydroquinone, retinoic acid, sodium lauryl sulfate, or urshiol) with or without recombinant IL-1ra treatment. Mouse skin was administered irritant concentrations of hydroquinone or retinoic acid. IL-1ra (mRNA and/or intracellular/extracellularly released protein) levels increased in the chemically treated cultured keratinocytes with IL-1 alpha. and IL-1 beta mRNAs and in the chemically exposed epidermis of the mouse skin. Recombinant IL-1ra treatment significantly reduced the chemically-induced apoptotic death and intracellular/extracellularly released IL-1 alpha and IL-1 beta in keratinocytes. Collectively, extracellular IL-1ra released from keratinocytes could be a compensatory mechanism to reduce the chemically-induced keratinocyte apoptosis by antagonism to IL-1 alpha and IL-1 beta, suggesting potential applications to predict skin irritation.Keywords
Funding Information
- Ministry of Health and Welfare(Ministry of Health, Welfare and Family Affairs) (HN15C0102)
- National Research Foundation of Korea(NRF)
- Ministry of Science, ICT and Future Planning(MSIP) (NRF-2017R1A2A2A09069507)
- Ministry of Food and Drug Safety(MFDS) (16182MFDS525)
This publication has 28 references indexed in Scilit:
- TLR3 mediates release of IL-1β and cell death in keratinocytes in a caspase-4 dependent mannerJournal of Dermatological Science, 2013
- Intracellular Interleukin-1 Receptor 2 Binding Prevents Cleavage and Activity of Interleukin-1α, Controlling Necrosis-Induced Sterile InflammationImmunity, 2013
- Intracellular Function of Interleukin-1 Receptor Antagonist in Ischemic CardiomyocytesPLOS ONE, 2013
- RXRα Ablation in Epidermal Keratinocytes Enhances UVR-Induced DNA Damage, Apoptosis, and Proliferation of Keratinocytes and MelanocytesJournal of Investigative Dermatology, 2011
- Differential release of chromatin-bound IL-1α discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammationProceedings of the National Academy of Sciences, 2010
- An Autoinflammatory Disease with Deficiency of the Interleukin-1–Receptor AntagonistNew England Journal of Medicine, 2009
- Stratum corneum cytokines and skin irritation response to sodium lauryl sulfateContact Dermatitis, 2006
- Interventions for photodamaged skin2005
- INTERLEUKIN-1 RECEPTOR ANTAGONIST: Role in BiologyAnnual Review of Immunology, 1998
- Electron microscopic observations of dyskeratosis, apoptosis, colloid bodies and fibrillar degeneration after skin irritation with dithranolJournal of Cutaneous Pathology, 1990